This study is looking at how people with breast cancer use herbs and supplements. It aims to understand if there are differences in usage based on ethnicity among patients treated at Cleveland Clinic in Florida and Ohio. You can join if you are 18 or older, have been diagnosed with stage I, II, or III breast cancer, have regional lymph node involvement, and have received chemotherapy and/or endocrine therapy. The study will measure how ethnicity influences the use of herbs and supplements among early-stage breast cancer participants after 5 months. The study is currently unclear on its recruitment status and plans to enroll 240 participants.

Study design

This is an observational study, meaning researchers will collect information without giving any specific treatment. It aims to enroll 240 participants.

What's involved

You would complete a one-time, 33-question survey about your demographic information, treatment, and use of herbs and supplements.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome, the influence of ethnicity on herb/supplement usage, will be measured at 5 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.